I gave Engerix B (hepatitis B vaccine) by mistake as the second dose of Twinrix (combined hepatitis A and B vaccine); how should I complete the hepatitis A and B vaccination series?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Managing an Inadvertent Engerix-B Dose as Second Dose of Twinrix Series

Count the Engerix-B dose as a valid second dose and complete the series with a third dose of Twinrix at the appropriate interval, ensuring the patient receives adequate hepatitis A protection. 1

Understanding the Error and Its Implications

When Engerix-B (monovalent hepatitis B vaccine) is mistakenly given as the second dose of a Twinrix series, the patient has received:

  • Dose 1 (Twinrix): 720 EL.U. hepatitis A antigen + 20 µg hepatitis B antigen 2
  • Dose 2 (Engerix-B): 20 µg hepatitis B antigen only (no hepatitis A component) 1

The critical issue is that the patient missed the second hepatitis A dose but received appropriate hepatitis B antigen. 1

Recommended Completion Strategy

Continue the series without restarting—the hepatitis B component is on track, but hepatitis A protection requires attention. 1

Step 1: Count the Engerix-B as Valid Dose #2 for Hepatitis B

  • The CDC explicitly states that mixing hepatitis B vaccine manufacturers does not compromise immunogenicity, and doses from different manufacturers are considered valid. 1
  • The Engerix-B dose (20 µg) provides the same hepatitis B antigen content as the Twinrix dose, so hepatitis B protection proceeds normally. 1
  • Do not restart the series—interrupted schedules should always be continued from where they left off. 1

Step 2: Complete with Third Dose of Twinrix

  • Administer the third dose of Twinrix at least 8 weeks after the Engerix-B dose (dose 2) and at least 16 weeks after the first Twinrix dose (dose 1). 1
  • The standard schedule would place this at month 6 from the initial dose, which satisfies both minimum interval requirements. 1
  • This third Twinrix dose will provide the second hepatitis A antigen exposure (720 EL.U.) and the third hepatitis B antigen exposure (20 µg). 2

Step 3: Consider Additional Hepatitis A Dose

After completing the modified Twinrix series, administer one additional dose of monovalent hepatitis A vaccine (Havrix or Vaqta) 6 months after the third Twinrix dose to ensure robust hepatitis A immunity. 3

Rationale:

  • The patient will have received only two hepatitis A antigen exposures (first Twinrix + third Twinrix) instead of the standard three. 2, 3
  • While two doses of hepatitis A vaccine provide substantial protection (approximately 95% after dose 1, virtually 100% after dose 2), the standard recommendation is a two-dose series at 0 and 6–12 months for monovalent vaccines. 3
  • Adding a fourth dose (monovalent hepatitis A) ensures the patient achieves the same hepatitis A protection as someone who completed a standard two-dose hepatitis A series. 3

Complete Corrected Schedule

Timing Vaccine Given Hepatitis A Doses Hepatitis B Doses
Month 0 Twinrix (dose 1) 1 1
Month 1 Engerix-B (dose 2) 1 2
Month 6 Twinrix (dose 3) 2 3
Month 12 Havrix or Vaqta 3 3

1, 2, 3

Alternative Simplified Approach (If Additional Dose Not Feasible)

If administering a fourth dose is impractical, the patient will still have adequate protection against both viruses with the modified three-dose series (Twinrix → Engerix-B → Twinrix). 1, 4

  • Hepatitis B: Three doses of 20 µg each provides >90% seroprotection in adults under 40 years. 1, 5
  • Hepatitis A: Two doses of 720 EL.U. each (from the two Twinrix doses) provides approximately 95–100% seroprotection. 3, 4

However, this approach deviates from standard schedules and may not provide optimal long-term hepatitis A immunity, particularly if the patient is at ongoing risk. 3

Critical Timing Rules

  • Minimum interval between doses 2 and 3: 8 weeks 1
  • Minimum interval between doses 1 and 3: 16 weeks 1
  • Grace period: Doses given ≤4 days before the minimum interval are valid 1
  • No maximum interval: Delays do not require restarting the series 1

Common Pitfalls to Avoid

  • Never restart the series—this wastes doses and delays protection. 1, 5
  • Do not give the third dose before 16 weeks from the first dose, even if 8 weeks have passed since the second dose. 1
  • Do not assume two hepatitis A doses are equivalent to three—while protection is high, the standard recommendation for Twinrix is three doses for optimal immunity. 2, 3
  • Do not use Twinrix solely for hepatitis B when hepatitis A is not indicated—but in this case, the patient already started Twinrix, so completing with Twinrix is appropriate. 3, 5
  • Document the error clearly in the patient's record to ensure future providers understand the modified schedule. 5

Post-Vaccination Considerations

  • Serologic testing is not routinely recommended for immunocompetent adults after completing the series. 1
  • Consider testing if the patient is immunocompromised, on hemodialysis, or has other risk factors for vaccine non-response. 1
  • Counsel the patient that they have received adequate hepatitis B protection but may benefit from the additional hepatitis A dose for optimal immunity. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vaccination Schedule for Twinrix

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Adult Hepatitis A and B Vaccination Schedules

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hepatitis B Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.